Kemmerly David L

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
19
Insider Sells Sum
$13.68M

Insider Activity of Kemmerly David L

The largest sale of all time was on 2020-05-05 and amounted to 23437 shares of Amedisys, Inc. for $4.11M.

Biography of Kemmerly David L

No biography is available at this moment.

2022-03-29SaleAmedisys, Inc.
AMED
See Remarks
443
0.0014%
$177.89$78,805-42.41%
2021-04-27SaleAmedisys, Inc.
AMED
See Remarks
4,875
0.0152%
$290.12$1.41M-41.17%
2021-04-09SaleAmedisys, Inc.
AMED
See Remarks
500
0.0015%
$280.00$140,000-39.55%
2021-04-01SaleAmedisys, Inc.
AMED
See Remarks
503
0.0015%
$270.00$135,810-35.48%
2020-06-09SaleAmedisys, Inc.
AMED
See Remarks
2,209
0.0068%
$176.81$390,583+43.27%
2020-05-05SaleAmedisys, Inc.
AMED
See Remarks
23,437
0.0714%
$175.32$4.11M+38.14%
2020-02-25SaleAmedisys, Inc.
AMED
See Remarks
202
0.0006%
$191.88$38,760+25.9%
2020-02-24SaleAmedisys, Inc.
AMED
See Remarks
1,116
0.0034%
$186.87$208,547+21.51%
2019-06-10SaleAmedisys, Inc.
AMED
See Remarks
8,125
0.0254%
$117.77$956,881+38.01%
2019-06-06SaleAmedisys, Inc.
AMED
See Remarks
4,420
0.0138%
$113.40$501,228+42.83%
2019-05-30SaleAmedisys, Inc.
AMED
See Remarks
5,000
0.0157%
$113.48$567,400+40.77%
2019-05-20SaleAmedisys, Inc.
AMED
See Remarks
5,000
0.0157%
$109.96$549,800+39.95%
2019-05-10SaleAmedisys, Inc.
AMED
See Remarks
5,000
0.0155%
$115.17$575,828+27.31%
2019-05-07SaleAmedisys, Inc.
AMED
See Remarks
5,000
0.0157%
$118.20$591,014+24.53%
2018-12-12SaleAmedisys, Inc.
AMED
See Remarks
6,250
0.0116%
$80.58$503,656-4.35%
2018-11-14SaleAmedisys, Inc.
AMED
See Remarks
6,250
0.019%
$116.88$730,480+7.86%
2018-11-09SaleAmedisys, Inc.
AMED
See Remarks
6,250
0.019%
$120.41$752,586+4.68%
2018-11-07SaleAmedisys, Inc.
AMED
See Remarks
6,750
0.0126%
$72.39$488,666+6.56%
2018-06-07SaleAmedisys, Inc.
AMED
See Remarks
12,000
0.0361%
$79.02$948,258+51.32%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.